| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 164 |
| 1 | PREDNISONE | 107 |
| 2 | METHOTREXATE SODIUM | 89 |
| 3 | METHOTREXATE | 78 |
| 4 | ETANERCEPT | 77 |
| 5 | ERGOCALCIFEROL | 75 |
| 6 | GABAPENTIN | 73 |
| 7 | ACETAMINOPHEN | 64 |
| 8 | ASPIRIN | 57 |
| 9 | OMEPRAZOLE MAGNESIUM | 56 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MENTHOL 10%, METHYL SALICYLATE 15% | 1 | 0.0769 |
| 1 | AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE | 1 | 0.0085 |
| 2 | EPINEPHRINE HYDROCHLORIDE | 3 | 0.0063 |
| 3 | PSYLLIUM HUSK | 6 | 0.0044 |
| 4 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 5 | BETAXOLOL HYDROCHLORIDE | 2 | 0.0038 |
| 6 | FLURANDRENOLIDE | 1 | 0.0030 |
| 7 | GOLIMUMAB | 36 | 0.0029 |
| 8 | PAMABROM | 1 | 0.0027 |
| 9 | LEVOKETOCONAZOLE | 2 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 165 |
| 1 | Corticosteroid [EPC] | 164 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 103 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 78 |
| 4 | Benzodiazepine [EPC] | 76 |
| 5 | Provitamin D2 Compound [EPC] | 75 |
| 6 | Proton Pump Inhibitor [EPC] | 66 |
| 7 | Vitamin C [EPC] | 66 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 60 |
| 9 | Interferon beta [EPC] | 56 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Cortisol Synthesis Inhibitor [EPC] | 2 | 0.0026 |
| 2 | Provitamin D2 Compound [EPC] | 75 | 0.0025 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 4 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 5 | Calcitonin [EPC] | 5 | 0.0016 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |
| 7 | alpha-Hydroxy Acid [EPC] | 2 | 0.0009 |
| 8 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 9 | beta Lactamase Inhibitor [EPC] | 3 | 0.0007 |